Legacy Bridge’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Legacy Bridge’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-630	Closed	-$59K	–	313
2021 Q4	$59K	Sell	630 -170	-21%	-$11.2K	0.03%	196
2021 Q3	$48K	Hold	800	–	–	0.03%	194
2021 Q2	$55K	Hold	800	–	–	0.03%	192
2021 Q1	$56K	Hold	800	–	–	0.04%	186
2020 Q4	$61K	Hold	800	–	–	0.04%	185
2020 Q3	$60K	Hold	800	–	–	0.05%	177
2020 Q2	$50K	Hold	800	–	–	0.06%	175
2020 Q1	$34K	Hold	800	–	–	0.04%	181
2019 Q4	$36K	Sell	800 -700	-47%	-$33.1K	0.03%	197
2019 Q3	$69K	Hold	1,500	–	–	0.07%	171
2019 Q2	$88K	Hold	1,500	–	–	0.08%	162
2019 Q1	$67K	Buy	+1,500	New	+$68.8K	0.07%	167

Legacy Bridge's ARNA Position: Q1 2022 in Review

Legacy Bridge sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 630 shares — an estimated $59K sold.

Legacy Bridge first reported a position in ARNA in Q1 2019 and held it in 12 quarters. The position peaked at $88K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Legacy Bridge reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Legacy Bridge sold 630 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $59K.
Legacy Bridge first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 12 quarters.
Legacy Bridge's Arena Pharmaceuticals Inc position peaked at $88K in Q2 2019.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Legacy Bridge's 13F filing for Q1 2022, filed 28 Apr 2022.